Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Deletion of the TNFAIP3/A20gene detected by FICTION analysis in classical Hodgkin lymphoma

  • Junko Nomoto1, 2,
  • Nobuhiro Hiramoto1,
  • Motohiro Kato3,
  • Masashi Sanada3,
  • Akiko Miyagi Maeshima4,
  • Hirokazu Taniguchi4,
  • Fumie Hosoda5,
  • Yoshitaka Asakura1,
  • Wataru Munakata1,
  • Naohiro Sekiguchi1,
  • Dai Maruyama1,
  • Takashi Watanabe1,
  • Hitoshi Nakagama6,
  • Kengo Takeuchi7,
  • Kensei Tobinai1,
  • Seishi Ogawa3 and
  • Yukio Kobayashi1Email author
BMC Cancer201212:457

DOI: 10.1186/1471-2407-12-457

Received: 30 May 2012

Accepted: 2 October 2012

Published: 5 October 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
30 May 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 Jun 2012 Author responded Author comments - Yukio Kobayashi
Resubmission - Version 3
7 Jun 2012 Submitted Manuscript version 3
8 Jul 2012 Reviewed Reviewer Report - Ralf Kueppers
28 Jul 2012 Reviewed Reviewer Report - Sylvia Hartmann
6 Sep 2012 Author responded Author comments - Yukio Kobayashi
Resubmission - Version 4
6 Sep 2012 Submitted Manuscript version 4
7 Sep 2012 Author responded Author comments - Yukio Kobayashi
Resubmission - Version 5
7 Sep 2012 Submitted Manuscript version 5
16 Sep 2012 Reviewed Reviewer Report - Ralf Kueppers
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
2 Oct 2012 Editorially accepted
5 Oct 2012 Article published 10.1186/1471-2407-12-457

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Hematology Division, National Cancer Center Hospital
(2)
Section of Microbiology and Immunology, Tokyo Medical and Dental University Graduate School of Health Care Sciences
(3)
Cancer Genomics, Faculty of Medicine, The University of Tokyo
(4)
Pathology Division, National Cancer Center Hospital
(5)
Cancer Genomics Division, National Cancer Center Research Institute
(6)
Early Carcinogenetic Division, Research Institute, National Cancer Center Hospital
(7)
Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research

Advertisement